+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 80Years
All Genders
ID07764094

Evaluating Procedural Factors of Drug-Coated Balloon Treatment in Coronary Artery Disease during PCI A Multicenter, Prospective, Observational Registry

Led by Nanjing First Hospital, Nanjing Medical University · Updated on 2026-08-28

500

Participants Needed

7

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating how procedural factors of drug-coated balloon DCB treatment affect patients with de novo coronary lesions undergoing percutaneous coronary intervention PCI. This observational registry focuses on delivery time from Y-to-B and inflation duration to understand their influence on angiographic and clinical outcomes. The goal is to analyze these impacts to potentially develop new techniques and pretreatment strategies to improve DCB treatment. Participants receive DCB treatment as part of their PCI procedure for new coronary artery lesions. The study observes the timing and duration aspects of the procedure without altering standard care. There is one main group of patients undergoing this DCB treatment strategy, and the study collects data during their routine PCI procedures. During the study, participants will be monitored for angiographic outcomes, including the occurrence of target lesion restenosis, and clinical outcomes such as target vessel failure, assessed between 6 to 12 months after treatment. The research team collects relevant clinical data and follows participants for up to approximately two years, ensuring safety and comprehensive outcome measurement throughout the study period.

CONDITIONS

Brief Title

Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease

Research Team

F

Fei Ye, MD

T

Tian-lei Zhang, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here